Albuminuria as a marker of the risk of developing type 2 diabetes in non-diabetic Aboriginal Australians

International Journal of Epidemiology

Volumn 35, Issue 5, 2006, Pages 1331-1335

  Wang, Zhiqiang ^a   Hoy, Wendy E ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Aboriginal health; Albuminuria; Case control; Diabetes in minorities; Epidemiology

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; GLUCOSE;

BODY MASS; DIABETES; EPIDEMIOLOGY; HEALTH RISK; INDIGENOUS POPULATION; LOGISTICS;

ABORIGINE; ADULT; AGE; AGED; ALBUMINURIA; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; FOLLOW UP; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; URINALYSIS; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ALBUMINURIA; ANTHROPOMETRY; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; NORTHERN TERRITORY; OCEANIC ANCESTRY GROUP; PROGNOSIS; RISK FACTORS;

AUSTRALASIA; AUSTRALIA;

EID: 33750219393     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyl115     Document Type: Article

References (31)

1. Wang Z, Hoy WE. Hypertension, dyslipidemia, body mass index, diabetes and smoking status in Aboriginal Australians in a remote community. Ethn Dis 2003;13:324-30.
2. Weinstein AR, Sesso HD, Lee IM, et al. Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA 2004;292:1188-94.
3. Hoy WE, Wang Z, VanBuynder P, Baker PR, McDonald SM, Mathews JD. The natural history of renal disease in Australian Aborigines. Part 2. Albuminuria predicts natural death and renal failure. Kidney Int 2001;60:249-56.
4. Wang Z, Hoy WE. Albuminuria and incident coronary heart disease in Australian Aboriginal people. Kidney Int 2005;68:1289-93.
5. Damsgaard EM, Mogensen CE. Microalbuminuria in elderly hyperglycaemic patients and controls. Diabet Med 1986;3:430-35.
6. Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M. Microalbuminuria precedes the development of NIDDM. Diabetes 1994;43:552-57.
7. Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT. Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 2005;28:2525-30.
8. Rowley KG, Iser DM, Best JD, O'Dea K, Leonard D, McDermott R. Albuminuria in Australian Aboriginal people: Prevalence and associations with components of the metabolic syndrome. Diabetologia 2000;43:1397-403.
9. McDonald SP, Maguire GP, Hoy WE. Renal function and cardiovascular risk markers in a remote Australian Aboriginal community. Nephrol Dial Transplant 2003;18:1555-61.
10. Hoy W, McDonald SP. Albuminuria: Marker or target in indigenous populations. Kidney Int Suppl 2004;S25-31.
11. Mogensen CE. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. J Intern Med 2003;254:45-66.
12. Mogensen CE, Keane WF, Bennett PH et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995;346:1080-84.
13. Yuyun MF, Khaw KT, Luben R et al. A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British population: The EPIC-Norfolk study. Am J Epidemiol 2004;159:284-93.
14. Hoy WE, Wang Z, VanBuynder P, Baker PR, Mathews JD. The natural history of renal disease in Australian Aborigines. Part 1. Changes in albuminuria and glomerular filtration rate over time. Kidney Int 2001;60:243-48.
15. Wang Z, Hoy WE. Association between diabetes and coronary heart disease in Aboriginal people: Are women disadvantaged? Med J Aust 2004;180:508-11.
16. Wang Z, Hoy WE. Waist circumference, body mass index, hip circumference and waist-to-hip ratio as predictors of cardiovascular disease in Aboriginal people. Eur J Clin Nutr 2004;58:888-93.
17. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications; Part 1: Diagnosis and Classification of Diabetes Melitus. Geneva: Department of Noncommunicable disease Surveillance, WHO, 1999.
18. StataCorp. Stata Statistical Software: Release 9.0. College Station. TX: StataCorp LP, 2005.
19. Lane JT. Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: A temporal perspective. Am J Physiol Renal Physiol 2004;286:F442-50.
20. Corona AJ, Martinez DR, Avila MH et al. Microalbuminuria as a predictor of myocardial infarction in a Mexican population: The Mexico City Diabetes Study. Kidney Int Suppl 2005;S34-39.
21. Haffner SM, Stern MP, Gruber MK, Hazuda HP, Mitchell BD, Patterson JK. Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 1990;10:727-31.
22. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1988;2:530-33.
23. Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: The insulin resistance atherosclerosis study. Diabetes 1998;47:793-800.
24. Palaniappan L, Carnethon M, Fortmann SP. Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens 2003;16:952-58.
25. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: The San Antonio heart study. Diabetes Care 2003;26:3153-59.
26. Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: Problems and prospects. Endocr Rev 1998;19:477-90.
27. Gerich JE. Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc 2003;78:447-56.
28. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992;15:815-19.
29. Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Deckert T. Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1989;1:461-63.
30. McDonald SP, Maguire GP, Duarte N, Wang XL, Hoy WE. Carotid intima-media thickness, cardiovascular risk factors and albuminuria in a remote Australian Aboriginal community. Atherosclerosis 2004; 177:423-31.
31. Houlihan CA, Tsalamandris C, Akdeniz A, Jerums G. Albumin to creatinine ratio: A screening test with limitations. Am J Kidney Dis 2002;39:1183-89.